👉👉 🇺🇸 All Posts 🇬🇧 / 🇯🇵 記事一覧 🇯🇵 👈👈
♦️ Introduction
Picture this: it’s postoperative day one after major abdominal surgery. Despite receiving opioids, your patient rates their pain as 7 out of 10 ⚡️. They can’t take deep breaths or get out of bed because it hurts too much 😣.
Ignoring this isn’t just about discomfort or asking patients to endure it—it carries real risks of preventable complications.
Uncontrolled acute pain isn’t limited to local discomfort. It’s a systemic physiological stressor that affects the entire body. Effective pain management isn’t only about comfort—it’s essential for preventing systemic complications, shortening hospital stays, and avoiding long-term disability ☝️.
♦️ Cardiovascular and Respiratory Impact
Severe pain triggers a surge in sympathetic nervous system activity. For a patient who should be recovering, this is a dangerous, full-blown “fight or flight” response.
🫀 Cardiovascular Effects
This sympathetic surge drives up heart rate, blood pressure, and vascular resistance. Together, these changes force the heart to work much harder than it should.
While young, healthy patients might tolerate this extra workload, patients with coronary artery disease face serious risks. The increased demand can reduce oxygen delivery to the myocardium, trigger arrhythmias, or even precipitate myocardial infarction.
Data clearly show that inadequate analgesia is associated with increased cardiac morbidity in high-risk surgical patients.
🫁 Respiratory Effects
You’ve seen it before—patients splint against incisional pain by taking shallow breaths and avoiding cough. This protective behavior prevents full lung expansion, leading to atelectasis and secretion retention. Reduced tidal volumes and impaired cough mechanics don’t just worsen oxygenation—they substantially increase the risk of pneumonia.
♦️ Immune and Endocrine Dysfunction
Pain doesn’t just affect comfort or breathing—it triggers a cascade of hormonal and immune responses. The same sympathetic surge activates the hypothalamic-pituitary-adrenal (HPA) axis, flooding the body with stress hormones like cortisol.
Here’s what happens—and as you’ll see, leaving postoperative pain uncontrolled offers no benefit 😓:
🛡️ Immune Suppression
Hypercortisolism suppresses the immune system and delays wound healing. The result? Higher rates of surgical site infection (SSI). Studies suggest that poorly controlled pain can increase infection rates by up to 50% 😫.
🔹 Metabolic Impact
This hormonal storm promotes protein breakdown and insulin resistance (increasing the risk of hyperglycemia), slowing tissue repair and prolonging the recovery phase.
🔹 GI Function
Pain and stress also slow gut motility, increasing the risk of postoperative (paralytic) ileus. This delays oral intake and prolongs hospitalization. In more severe cases, prolonged ileus increases aspiration risk and worsens respiratory function.
⚡️ The Acute-to-Chronic Pain Transition
Most people think postoperative pain is purely an acute-phase issue. Usually, that’s true—but poorly controlled acute pain can evolve into chronic pain 😖. Chronic postsurgical pain (CPSP) affects approximately 10–20% of surgical patients and can persist for months or even years.
One of the strongest predictors? The intensity of pain during the first 48–72 hours after surgery. Multiple studies confirm that early pain intensity strongly influences whether chronic pain develops later.
The mechanism is central sensitization—the nervous system continues to amplify pain signals even after tissues have healed.
💡 Key Point: Control pain aggressively during the first 24–72 hours. This isn’t just for comfort—it helps prevent neuroplastic changes in the spinal cord and brain that perpetuate pain.
☝️ The Solution: Proactive Multimodal Analgesia
Given these risks, relying solely on opioids isn’t sufficient. Major guidelines from the ASA, APS, and ASRA emphasize proactive multimodal analgesia as the standard of care.
So, how does it work? Think of it as targeting pain from multiple mechanisms simultaneously
- NSAIDs reduce peripheral inflammation, while acetaminophen provides central analgesic effects.
- Gabapentinoids (pregabalin and mirogabalin) help modulate nerve sensitization.
- Regional anesthesia (nerve blocks, epidurals) stops pain signals at their source.
- IV ketamine helps prevent central sensitization in opioid-tolerant patients.
🌐 International Note
While multimodal analgesia is widely practiced globally, some medications (such as IV ketamine for postoperative or chronic pain) may still be considered off-label in certain countries, including Japan. Always follow your institution’s protocols and local regulatory standards.
Gabapentinoid administration for preoperative pain prevention may also be off-label in some regions. For example, while pregabalin is approved for neuropathic pain in Japan, its use for postoperative pain prevention may require ethics committee approval or off-label use procedures. Informed consent is essential.
✅ The Benefit
This multimodal strategy delivers superior pain relief while reducing opioid consumption by approximately 30–40%. Less opioid means fewer side effects—less respiratory depression, sedation, nausea, and ileus—leading to shorter hospital stays and faster overall recovery 👍.
📝 Summary: Take-Home Messages
Postoperative pain isn’t just a symptom—it’s a stressor that profoundly affects the heart, lungs, and immune system. Proactive management with multimodal strategies is essential for preventing complications and chronic pain.
🔑 Key Points
- High Prevalence: Approximately 75–80% of patients experience moderate to severe postoperative pain, making consistent assessment and proactive management a critical part of perioperative care.
- Chronic Pain Risk: Severe pain during the first 48–72 hours is the strongest predictor of CPSP, which affects 10–20% of surgical patients.
- Systemic Cardiovascular Harm: Pain-induced sympathetic activation increases heart rate and blood pressure, raising the risk of ischemia in cardiac patients.
- Respiratory Complications: Shallow breathing and poor cough effort lead to atelectasis and pneumonia.
- Standard of Care: Multimodal analgesia (non-opioid drugs, regional blocks, adjuvant agents) improves pain control while reducing opioid use by approximately one-third (always consider appropriate indications).
📚 References & Further reading
- Chou R et al. Management of postoperative pain. J Pain. 2016;17(2):131-157. doi:10.1016/j.jpain.2015.12.008. Available from: https://pubmed.ncbi.nlm.nih.gov/26827847/ [Open Access]
- Horn R, Hendrix JM, Kramer J. Postoperative Pain Control. StatPearls [Internet]. 2024 Jan 30. Available from: https://www.ncbi.nlm.nih.gov/books/NBK544298/ [Open Access]
- The Management of Postoperative Pain. US Pharmacist. 2024 Mar 13. Available from: https://www.uspharmacist.com/article/the-management-of-postoperative-pain [Open Access]
🔗 Related articles
- to be added
